-
Gilead's Trop-2 antibody conjugate drug gains second indication
Time of Update: 2021-04-18
S. FDA has accelerated the approval of its Trop-2 antibody conjugate drug Trodelvy (sacituzumab govitecan-hziy) to expand its scope of use for the treatment of locally advanced or metastatic urothelium Cancer patients.
-
The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-18
Introduction: Enzymes that play a major role in cancer and type 2 diabetes can also activate the "clear" protein in Parkinson's disease.
-
IDH1/2 inhibitor Ivosidenib/Enasidenib combined with intensive chemotherapy is well tolerated in newly treated AML patients
Time of Update: 2021-04-18
Research methods The study included newly-treated AML patients aged ≥18 years, ECOG score 0-2, and IDH1/2 mutations, who received 500mg/day Ivosidenib/Enasidenib combined with cytarabine (200mg/m2/day, total 7 Day) and daunorubicin (60mg/m2/day for 3 days) induction therapy.
-
Kelun Class 1 new drug hits 2 billion injections, the first four major products that have been reviewed and will be approved
Time of Update: 2021-04-18
hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal alanine Acylglutamine injection exceeds 2 billion yuan. This product
-
Xinjiang’s “2+4” Drug Purchasing Alliance Came to Promote Inter-provincial Centralized Procurement
Time of Update: 2021-04-18
The pace is accelerating, and another inter-provincial alliance brings a lot of purchases Xinjiang "2+4
-
Express | Gilead's Trop-2 antibody-conjugated drug gains second indication for the treatment of bladder cancer
Time of Update: 2021-04-18
S. FDA has accelerated its approval of its Trop-2 antibody conjugate drug Trodelvy (sacituzumab govitecan-hziy) to expand the scope of use for local treatment Patients with advanced or metastatic urothelial cancer.
-
16 new cases were confirmed on April 11, and 2 local cases were in Yunnan
Time of Update: 2021-04-17
on April 11, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps reported 16 new confirmed cases, including 14 imported cases (4 in Fujian, 3 in Shanghai, 3 in Guangdong, Shaanxi) 2 cases, 1 case
-
and Monitoring Information of Food Safety Supervision in 2021 (Phase 2)
Time of Update: 2021-04-17
1. 7 batches of beverages, the inspection items are acesulfame potassium, benzoic acid and its sodium salt (calculated as benzoic acid), coliforms, protein, carbon dioxide gas capacity
-
Sci Adv: The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-17
called Parkin is eager to protect mitochondria, which are power plants that generate energy for cells. Recently, Salk researchers discovered a direct connection
-
Linyi City Market Supervision Administration Announcement on Food Safety Supervision and Sampling Inspection Information in the First Quarter (2)
Time of Update: 2021-04-17
html" class="zdbq" title="Meat related food information" target="_blank">meat products , foodmate.
html" class="zdbq" title="Meat related food information" target="_blank">meat products , foodmate.
-
Yangquan Market Supervision Administration Announcement on Food Safety Supervision Sampling Inspection Information in 2021 (Phase 2)
Time of Update: 2021-04-17
html" class="zdbq" title="Food information related to national food safety standards" target="_blank">national food safety standards : 65 batches of qualified samples and 1 batch of unqualified samples were foodmate.
-
How to deal with the California variant of SARS-CoV-2?
Time of Update: 2021-04-16
The results of the study also showed that the L452R mutation of SARS-CoV-2 reduced the neutralizing activity of the plasma of vaccinators and convalescent donors.
-
Express | Treatment of Alzheimer's disease, telomerase modulator positive phase 2 clinical results released
Time of Update: 2021-04-14
▎The content team editor of WuXi AppTec
-
5 points, 2 charts, quickly master the 2020 American Gastroenterological Association Guideline for Moderate-Severe Ulcerative Colitis
Time of Update: 2021-04-14
Only for medical professionals to read
-
AstraZeneca/Daiichi Sankyo launches global phase 2 clinical trial: Enhertu treats HER2 mutant lung cancer
Time of Update: 2021-04-14
AstraZeneca and Daiichi Sankyo jointly announced recently that the global phase 2 clinical trial DESTINY-Lung02 has
-
Can these two types of metabolic surgery cure type 2 diabetes?
Time of Update: 2021-04-14
*Only for medical professionals to read
-
R&D | Current status of the prevention and application of probiotics in type 2 diabetes
Time of Update: 2021-04-14
In recent years, microecological regulators have made great progress in regulating the intestinal microecology and improving
-
/refractory follicular lymphoma Phase 2 registration clinical results are gratifying
Time of Update: 2021-04-14
Linperlisib (YY-20394 tablets) significantly
-
Highlights of Science Journal on April 2, 2021
Time of Update: 2021-04-14
